Status:
UNKNOWN
Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery
Lead Sponsor:
Sheikh Zayed Medical College
Conditions:
Hemodynamic Stability
Eligibility:
All Genders
18-40 years
Phase:
EARLY_PHASE1
Brief Summary
Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent m...
Eligibility Criteria
Inclusion
- middle age(18\_40)
- Asa 1 and 2
- Non hypertensive
- Thyroid patients
- patient who gives consent
Exclusion
- hypertensive
- Asa 3 and 4
- Patient refusal
Key Trial Info
Start Date :
December 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05298761
Start Date
December 30 2023
End Date
June 1 2024
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr.amna
Rahim Yar Khan, Punjab Province, Pakistan, 092